U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H11ClN2O3
Molecular Weight 314.723
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TESICAM

SMILES

ClC1=CC=C(NC(=O)C2C(=O)NC(=O)C3=C2C=CC=C3)C=C1

InChI

InChIKey=HWCORKBTTGTRDY-UHFFFAOYSA-N
InChI=1S/C16H11ClN2O3/c17-9-5-7-10(8-6-9)18-15(21)13-11-3-1-2-4-12(11)14(20)19-16(13)22/h1-8,13H,(H,18,21)(H,19,20,22)

HIDE SMILES / InChI

Molecular Formula C16H11ClN2O3
Molecular Weight 314.723
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Tesicam is a dioxoisoquinoline derivative patented by Pfizer, Chas. and Co., Inc. as an anti-inflammatory agent. In preclinical models, Tesicam shows potent anti-inflammatory activity against carrageenin-induced edema in rats.

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
8X48DWE4EM
Record Status Validated (UNII)
Record Version